pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 9·1 min read
save

A different approach to lowering healthcare costs

Last month, Garner Health raised $100 million, vaulting its valuation to $2.7 billion. At first, this startup sounded more like a doctor-rankings company, which I’d typically think of as more ...

Jun 9, 2026·read at Endpoints ↗

June 9, 2026 12:03 PM EDT Health Tech A dif­fer­ent ap­proach to low­er­ing health­care costs Lydia Ramsey Pflanzer Deputy Editor Last month, Gar­ner Health raised $100 mil­lion, vault­ing its val­u­a­tion to $2.7 bil­lion. At first, this start­up sound­ed more like … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
75 words · retrieved Jun 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoLeo Pharma to license Tanabe’s rare disease drug for pain with sun exposureEndpoints
  • 13h agoAI will be better than doctors at some medical tasks, healthcare and VC experts predictEndpoints
  • 16h agoDrugmakers voice support of US probe into Germany’s drug pricing plansEndpoints
  • 18h agoEyePoint’s bid to compete with Eylea falls flatEndpoints
  • 19h agoBiotech's reverse merger renaissance poised to continueEndpoints